News
All news
Follow our analyses, statements and news from the MENA region.
100% Life, Initiativa Pozitivă, ITPC MENA, ATL MST-SIDA, and Salud por Derecho Filed Third-Party Observation at the European Patent Office Against Merck’s Patent Application on the HIV Prevention Pill Alimatravir (MK-8527)
Source : ITPC-Make Medecine Affordable Campaign Kyiv–Chișinău–Rabat–Tunis–Madrid, 24 September 2026 – 100% Life (Ukraine), Initiativa Pozitivă/Positive Initiative (Moldova), the International Treatment Preparedness Coalition – Middle East and North Africa (ITPC MENA), ATL MST-SIDA (Tunisia), and Salud por Derecho (Spain) have jointly filed a third-party observation with the European Patent Office (EPO) opposing a patent application […]
Read →
Global Fund Results Report 2026: What the Numbers Say About the Middle East and North Africa Region
The Global Fund to Fight AIDS, Tuberculosis and Malaria’s report reviews 2025. It highlights the resilience of programs in the face of unprecedented budget cuts. Here is what it says about the MENA region.
Read →
Defining, Not Receiving | Perspectives on Health Governance Reform in the Middle East & North Africa
This report brings MENA evidence and perspectives into the Global Health Architecture reform, highlighting the need for stronger civil society participation and a more inclusive, responsive and accountable approach to global health governance.
Read →
ITPC-MENA at AIDS 2026: A Region That Refuses to Stay in the Margins
At AIDS 2026 in Rio de Janeiro, ITPC-MENA brought MENA’s community evidence, priorities and perspectives into the global HIV conversation. From community-led monitoring and access to medicines to long-acting PrEP and strategic partnerships, the region made its priorities clear: MENA cannot be an afterthought in the global HIV response.
Read →
We’re on the Map: The MENA Roadmap to AIDS 2026
Every session where our region is represented, discussed, or defended — and where to find us in Rio. From 26 to 31 July, the XXIV International AIDS Conference (AIDS 2026) convenes in Rio de Janeiro under the theme Rethink. Rebuild. Rise. It gathers at the most financially uncertain moment the HIV response has faced — funding shrinking, […]
Read →
Global Fund replenishment: the Gulf Cooperation Council (GCC) must announce its pledge before the next Board Meeting
Statement from 46 Organizations Wednesday, December 3rd, 2025 As the world faces unprecedented health challenges, the Middle East and North Africa (MENA) region is entering a critical phase marked by an accelerating health crisis. The region is experiencing the fastest-growing HIV epidemic globally, alongside a rising burden of tuberculosis and fragile health systems in several […]
Read →
Terms of Reference for the Recruitment of a Consultant for Policy Brief Development
Position Title: Consultant for Policy Brief Development on the Global Fund’s Impact in the MENA Region for GC8 Organization(s): ITPC-MENA and MENA H Coalition Duration of Consultancy: 5 effective working days Background : The Middle East and North Africa (MENA) region is experiencing a growing HIV epidemic, characterized by specific challenges in data availability and policy […]
Read →
A Powerful Tribute to Professor Hakima Himmich: A Life of Courage, Justice, and Resistance
🗓️ On May 13, 2025, during the 3rd Global Summit on Intellectual Property and Access to Medicines (GSIPA2M2025) held in Marrakech and co-organized by ITPC-MENA, a deeply emotional moment captured the audience. A powerful tribute was paid to Professor Hakima Himmich, a true icon in the fight for health and social justice – in Morocco, across the MENA region, and far […]
Read →
HIV PREVENTION & ACCOUNTABILITY: A MULTI-COUNTRY COMMUNITY PERSPECTIVE 2025
This report provides a civil society analysis of the HIV prevention response, outlining the progress and gaps in five countries: Egypt, Jordan, Lebanon, Morocco, and Tunisia. The findings inform a set of key recommendations aimed at addressing these urgent challenges and strengthening the response in MENA. DOWNLOAD PDF تنزيل ملف PDF TÉLÉCHARGER PDF Frontline AIDS […]
Read →
Call for Consultant: Acceptance Study of New Generation Long-Acting ARVs Among PLWHIV in the MENA Region
Terms of Reference (ToR) for ConsultationDemand Creation for New Generation ARVs – Acceptance Study Among PLWHIV 1. Context and Justification The Middle East and North Africa (MENA) region faces a growing HIV epidemic, characterized by increasing uncertainties regarding its incidence and consequences. Data indicate that AIDS-related deaths surged by 66% between 2005 and 2013, emphasizing […]
Read →
The MENA H Coalition calls for sustained investments in the fight against tuberculosis in the MENA region
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the MENA-H Coalition issues an urgent call to intensify efforts to eliminate tuberculosis (TB) in the Middle East and North Africa (MENA) […]
Read →
Results of a study on lenacapavir and two broadly neutralizing antibodies were presented at CROI 2025.
At the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, results were presented from a Phase II study examining the efficacy of a combination of lenacapavir (TN Sunlenca) and two broadly neutralizing antibodies (bNAbs) – teropavimab and zinlirvimab. The study results indicate that this regimen could form the basis of a complete […]
Read →